{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:38:34Z","timestamp":1790876314590,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T00:00:00Z","timestamp":1379721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1472-6882-13-231","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T19:03:18Z","timestamp":1379790198000},"source":"Crossref","is-referenced-by-count":33,"title":["Plant proteolytic enzyme papain abrogates angiogenic activation of human umbilical vein endothelial cells (HUVEC) in vitro"],"prefix":"10.1186","volume":"13","author":[{"given":"Thomas","family":"Mohr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Desser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,21]]},"reference":[{"key":"1481_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature. 2000, 407: 249-257. 10.1038\/35025220.","journal-title":"Nature"},{"key":"1481_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/339058a0","volume":"339","author":"J Folkman","year":"1989","unstructured":"Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989, 339: 58-61. 10.1038\/339058a0.","journal-title":"Nature"},{"key":"1481_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.critrevonc.2006.11.006","volume":"62","author":"X Dong","year":"2007","unstructured":"Dong X, Han ZC, Yang R: Angiogenesis and antiangiogenic therapy in hematologic malignancies. Crit Rev Oncol Hematol. 2007, 62: 105-118. 10.1016\/j.critrevonc.2006.11.006.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1481_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.drudis.2007.08.018","volume":"12","author":"J Jacobs","year":"2007","unstructured":"Jacobs J: Combating cardiovascular disease with angiogenic therapy. Drug Discov Today. 2007, 12: 1040-1045. 10.1016\/j.drudis.2007.08.018.","journal-title":"Drug Discov Today"},{"key":"1481_CR5","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1161\/CIRCULATIONAHA.105.535294","volume":"112","author":"R Khurana","year":"2005","unstructured":"Khurana R, Simons M, Martin JF, Zachary IC: Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal. Circulation. 2005, 112: 1813-1824. 10.1161\/CIRCULATIONAHA.105.535294.","journal-title":"Circulation"},{"key":"1481_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/01.mol.0000245261.71129.f0","volume":"17","author":"KS Moulton","year":"2006","unstructured":"Moulton KS: Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol. 2006, 17: 548-555. 10.1097\/01.mol.0000245261.71129.f0.","journal-title":"Curr Opin Lipidol"},{"key":"1481_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrm2183","volume":"8","author":"RH Adams","year":"2007","unstructured":"Adams RH, Alitalo K: Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007, 8: 464-478. 10.1038\/nrm2183.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1481_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1042\/BJ20110301","volume":"437","author":"S Koch","year":"2011","unstructured":"Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L: Signal transduction by vascular endothelial growth factor receptors. Biochem J. 2011, 437: 169-183. 10.1042\/BJ20110301.","journal-title":"Biochem J"},{"key":"1481_CR9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/PL00000936","volume":"58","author":"HR Maurer","year":"2001","unstructured":"Maurer HR: Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001, 58: 1234-1245. 10.1007\/PL00000936.","journal-title":"Cell Mol Life Sci"},{"key":"1481_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.canlet.2009.08.001","volume":"290","author":"K Chobotova","year":"2010","unstructured":"Chobotova K, Vernallis A, Majid F: Bromelain\u2019s activity and potential as an anti-cancer agent: Current evidence and perspectives. Cancer Lett. 2010, 290: 148-156. 10.1016\/j.canlet.2009.08.001.","journal-title":"Cancer Lett"},{"key":"1481_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/BF02252938","volume":"45","author":"M Majima","year":"1996","unstructured":"Majima M, Nishiyama K, Iguchi Y, Yao K, Ogino M, Ohno T, Sunahara N, Katoh K, Tatemichi N, Takei Y, Katori M: Determination of bradykinin-(1\u20135) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation. Inflamm Res. 1996, 45: 416-423. 10.1007\/BF02252938.","journal-title":"Inflamm Res"},{"key":"1481_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/BF02252946","volume":"45","author":"M Ogino","year":"1996","unstructured":"Ogino M, Majima M, Kawamura M, Hatanaka K, Saito M, Harada Y, Katori M: Increased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: roles of complement, bradykinin, and inducible cyclooxygenase-2. Inflamm Res. 1996, 45: 335-346. 10.1007\/BF02252946.","journal-title":"Inflamm Res"},{"key":"1481_CR13","first-page":"728","volume":"50","author":"A Wittenborg","year":"2000","unstructured":"Wittenborg A, Bock PR, Hanisch J, Saller R, Schneider B: Comparative epidemiological study in patients with rheumatic diseases illustrated in a example of a treatment with non-steroidal anti- inflammatory drugs versus an oral enzyme combination preparation. Arzneimittelforschung. 2000, 50: 728-738.","journal-title":"Arzneimittelforschung"},{"key":"1481_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s10067-004-0902-y","volume":"23","author":"NM Akhtar","year":"2004","unstructured":"Akhtar NM, Naseer R, Farooqi AZ, Aziz W, Nazir M: Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee\u2013a double-blind prospective randomized study. Clin Rheumatol. 2004, 23: 410-415. 10.1007\/s10067-004-0902-y.","journal-title":"Clin Rheumatol"},{"key":"1481_CR15","first-page":"303","volume":"113","author":"M Masson","year":"1995","unstructured":"Masson M: Bromelain in blunt injuries of the locomotor system. A study of observed applications in general practice. Fortschr Med. 1995, 113: 303-306.","journal-title":"Fortschr Med"},{"key":"1481_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0952-3278(94)90065-5","volume":"51","author":"K Inoue","year":"1994","unstructured":"Inoue K, Motonaga A, Dainaka J, Nishimura T, Hashii H, Yamate K, Ueda F, Kimura K: Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation. Prostaglandins Leukot Essent Fatty Acids. 1994, 51: 457-462. 10.1016\/0952-3278(94)90065-5.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1481_CR17","first-page":"1191","volume":"6","author":"K Eckert","year":"1999","unstructured":"Eckert K, Grabowska E, Stange R, Schneider U, Eschmann K, Maurer HR: Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients. Oncol Rep. 1999, 6: 1191-1199.","journal-title":"Oncol Rep"},{"key":"1481_CR18","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.4049\/jimmunol.149.12.3809","volume":"149","author":"LP Hale","year":"1992","unstructured":"Hale LP, Haynes BF: Bromelain treatment of human T cells removes CD44, CD45RA, E2\/MIC2, CD6, CD7, CD8, and Leu 8\/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol. 1992, 149: 3809-3816.","journal-title":"J Immunol"},{"key":"1481_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0014-5793(94)00860-4","volume":"351","author":"E Munzig","year":"1994","unstructured":"Munzig E, Eckert K, Harrach T, Graf H, Maurer HR: Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to human umbilical vein endothelial cells. FEBS Lett. 1994, 351: 215-218. 10.1016\/0014-5793(94)00860-4.","journal-title":"FEBS Lett"},{"key":"1481_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/clim.2002.5254","volume":"104","author":"LP Hale","year":"2002","unstructured":"Hale LP, Greer PK, Sempowski GD: Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol. 2002, 104: 183-190. 10.1006\/clim.2002.5254.","journal-title":"Clin Immunol"},{"key":"1481_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2009.03.003","volume":"282","author":"K Bhui","year":"2009","unstructured":"Bhui K, Prasad S, George J, Shukla Y: Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett. 2009, 282: 167-176. 10.1016\/j.canlet.2009.03.003.","journal-title":"Cancer Lett"},{"key":"1481_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.taap.2007.08.012","volume":"226","author":"N Kalra","year":"2008","unstructured":"Kalra N, Bhui K, Roy P, Srivastava S, George J, Prasad S, Shukla Y: Regulation of p53, nuclear factor \u03baB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol Appl Pharmacol. 2008, 226: 30-37. 10.1016\/j.taap.2007.08.012.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1481_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/mc.20769","volume":"51","author":"K Bhui","year":"2012","unstructured":"Bhui K, Tyagi S, Srivastava AK, Singh M, Roy P, Singh R, Shukla Y: Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G(2)\/M arrest to apoptosis. Mol Carcinog. 2012, 51: 231-243. 10.1002\/mc.20769.","journal-title":"Mol Carcinog"},{"key":"1481_CR24","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1021\/jf052390k","volume":"54","author":"RC-W Hou","year":"2006","unstructured":"Hou RC-W, Chen Y-S, Huang J-R, Jeng K-CG: Cross-Linked Bromelain Inhibits Lipopolysaccharide-Induced Cytokine Production Involving Cellular Signaling Suppression in Rats. J Agric Food Chem. 2006, 54: 2193-2198. 10.1021\/jf052390k.","journal-title":"J Agric Food Chem"},{"key":"1481_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2144\/000113083","volume":"46","author":"T Geb\u00e4ck","year":"2009","unstructured":"Geb\u00e4ck T, Schulz MMP, Koumoutsakos P, Detmar M: TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques. 2009, 46: 265-274.","journal-title":"Biotechniques"},{"key":"1481_CR26","first-page":"876","volume-title":"Microscopy: Science, Technology, Applications and Education, Volume 2","author":"D Guidolin","year":"2010","unstructured":"Guidolin D, Albertin G, Ribatti D: Exploring in vitro angiogenesis by image analysis and mathematical modeling. Microscopy: Science, Technology, Applications and Education, Volume 2. Edited by: M\u00e9ndez-Vilas A, Diaz J. 2010, Badajoz, Spain: Formatex, 876-884."},{"key":"1481_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2144\/000112257","volume":"42","author":"MR Lamprecht","year":"2007","unstructured":"Lamprecht MR, Sabatini DM, Carpenter AE: Cell Profiler: free, versatile software for automated biological image analysis. Biotechniques. 2007, 42: 71-75. 10.2144\/000112257.","journal-title":"Biotechniques"},{"key":"1481_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0005-1098(75)90044-8","volume":"11","author":"N Otsu","year":"1975","unstructured":"Otsu N: A threshold selection method from gray-level histograms. Automatica. 1975, 11: 285-296. 10.1016\/0005-1098(75)90044-8.","journal-title":"Automatica"},{"key":"1481_CR29","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.bbamcr.2012.08.017","volume":"1823","author":"AM Martelli","year":"2012","unstructured":"Martelli AM, Tabellini G, Bressanin D, Ognibene A, Goto K, Cocco L, Evangelisti C: The emerging multiple roles of nuclear Akt. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2012, 1823: 2168-2178. 10.1016\/j.bbamcr.2012.08.017.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"1481_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0960-9822(99)80164-X","volume":"9","author":"S Giroux","year":"1999","unstructured":"Giroux S, Tremblay M, Bernard D, Cardin-Girard JF, Aubry S, Larouche L, Rousseau S, Huot J, Landry J, Jeannotte L, Charron J: Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol. 1999, 9: 369-372. 10.1016\/S0960-9822(99)80164-X.","journal-title":"Curr Biol"},{"key":"1481_CR31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0006-2952(00)00423-8","volume":"60","author":"E Berra","year":"2000","unstructured":"Berra E, Milanini J, Richard DE, Le Gall M, Vi\u00f1als F, Gothi\u00e9 E, Roux D, Pag\u00e8s G, Pouyss\u00e9gur J: Signaling angiogenesis via p42\/p44 MAP kinase and hypoxia. Biochem Pharmacol. 2000, 60: 1171-1178. 10.1016\/S0006-2952(00)00423-8.","journal-title":"Biochem Pharmacol"},{"key":"1481_CR32","first-page":"5911","volume":"61","author":"G Dong","year":"2001","unstructured":"Dong G, Chen Z, Li Z-Y, Yeh NT, Bancroft CC, Van Waes C: Hepatocyte Growth Factor\/Scatter Factor-induced Activation of MEK and PI3K Signal Pathways Contributes to Expression of Proangiogenic Cytokines Interleukin-8 and Vascular Endothelial Growth Factor in Head and Neck Squamous Cell Carcinoma. Cancer Res. 2001, 61: 5911-5918.","journal-title":"Cancer Res"},{"key":"1481_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1158\/0008-5472.CAN-07-5311","volume":"68","author":"D Huang","year":"2008","unstructured":"Huang D, Ding Y, Luo W-M, Bender S, Qian C-N, Kort E, Zhang Z-F, VandenBeldt K, Duesbery NS, Resau JH, Teh BT: Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivo. Cancer Res. 2008, 68: 81-88. 10.1158\/0008-5472.CAN-07-5311.","journal-title":"Cancer Res"},{"key":"1481_CR34","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.4049\/jimmunol.163.5.2568","volume":"163","author":"TL Mynott","year":"1999","unstructured":"Mynott TL, Ladhams A, Scarmato P, Engwerda CR: Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells. J Immunol. 1999, 163: 2568-75.","journal-title":"J Immunol"},{"key":"1481_CR35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1096\/fj.02-0329fje","volume":"17","author":"K Issbr\u00fccker","year":"2003","unstructured":"Issbr\u00fccker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A, Breier G, Drexler HCA, Suttorp N, Clauss M: p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J. 2003, 17: 262-264.","journal-title":"FASEB J"},{"key":"1481_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda \u00c1R: Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009, 9: 537-549. 10.1038\/nrc2694.","journal-title":"Nat Rev Cancer"},{"key":"1481_CR37","doi-asserted-by":"publisher","first-page":"C659","DOI":"10.1152\/ajpcell.00211.2004","volume":"288","author":"PJ Boyd","year":"2005","unstructured":"Boyd PJ, Doyle J, Gee E, Pallan S, Haas TL: MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. Am J Physiol Cell Physiol. 2005, 288: C659-C668.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1481_CR38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cellbi.2008.03.005","volume":"32","author":"C Uchida","year":"2008","unstructured":"Uchida C, Gee E, Ispanovic E, Haas T: JNK as a positive regulator of angiogenic potential in endothelial cells. Cell Biol Int. 2008, 32: 769-776. 10.1016\/j.cellbi.2008.03.005.","journal-title":"Cell Biol Int"},{"key":"1481_CR39","doi-asserted-by":"publisher","first-page":"20995","DOI":"10.1074\/jbc.M407060200","volume":"280","author":"ME McMullen","year":"2005","unstructured":"McMullen ME, Bryant PW, Glembotski CC, Vincent PA, Pumiglia KM: Activation of p38 Has Opposing Effects on the Proliferation and Migration of Endothelial Cells. J Biol Chem. 2005, 280: 20995-21003. 10.1074\/jbc.M407060200.","journal-title":"J Biol Chem"},{"key":"1481_CR40","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/jcp.22404","volume":"226","author":"G Rajashekhar","year":"2011","unstructured":"Rajashekhar G, Kamocka M, Marin A, Suckow MA, Wolter WR, Badve S, Sanjeevaiah AR, Pumiglia K, Rosen E, Clauss M: Pro-inflammatory angiogenesis is mediated by p38 MAP kinase. J Cell Physiol. 2011, 226: 800-808. 10.1002\/jcp.22404.","journal-title":"J Cell Physiol"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-13-231\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-13-231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-13-231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-13-231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T18:56:48Z","timestamp":1688497008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-13-231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,21]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1481"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-13-231","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,21]]},"article-number":"231"}}